Welltower Q1 2026 Blowout: SSNOI Growth Still Above 20%, Balance Sheet Strengthens

What happened

Welltower reported first quarter 2026 normalized FFO of $1.47 per share, up 23% year-over-year, driven by seniors housing operating same-store NOI growth of 22.1% on 370 bps of occupancy gains and 5.0% RevPOR growth. The company closed $3.3 billion of investments in the quarter and has an additional $7.2 billion under contract, while also completing $2.8 billion of dispositions, including follow-on tranches of the outpatient medical portfolio sale. Leverage dropped sharply, with net debt to EBITDA at 2.73x and net debt to enterprise value at 8.8%, reflecting strong capital recycling and equity issuance. Despite the stellar operational performance, the stock continues to trade at a premium valuation (over 130x trailing GAAP earnings), embedding expectations that this level of growth can be sustained. The key question is whether integration of over 700 recently acquired communities and eventual normalization of occupancy gains will allow the company to maintain double-digit SSNOI growth as the cycle matures.

Implication

The significantly improved balance sheet reduces downside risk, but the core growth thesis still depends on sustaining above-trend SSNOI. At current multiples, risk-reward is balanced; consider holding but not adding until a clearer entry point near $155.

Thesis delta

The balance sheet improvement (net debt/EBITDA 2.73x vs prior ~4.8x) materially lowers leverage risk, but the core growth thesis remains dependent on sustaining above-trend SSNOI. The earlier POTENTIAL SELL rating could be reassessed toward a more neutral stance given stronger balance sheet cushion, though valuation still limits upside potential.